CN1943732A - A medicinal composition for treatment of psoriasis - Google Patents
A medicinal composition for treatment of psoriasis Download PDFInfo
- Publication number
- CN1943732A CN1943732A CN 200610096625 CN200610096625A CN1943732A CN 1943732 A CN1943732 A CN 1943732A CN 200610096625 CN200610096625 CN 200610096625 CN 200610096625 A CN200610096625 A CN 200610096625A CN 1943732 A CN1943732 A CN 1943732A
- Authority
- CN
- China
- Prior art keywords
- fructus
- radix
- pharmaceutical composition
- treatment
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A medical composition that cures for Psoriasis is described. It is characterized in that it is a kind of granular medicament including some raw material made by the following ratio of weight: Radix Codonopsis 10~30, Rhizoma Atractylodis Macrocephalae 1~5, Fructus Crataegi 10~30, Fructus Hordei Germinatus 1~5, Poria 1~5, Semen Raphani 1~5, Radix Glycyrrhizae 10~30, Radix et Rhizoma Salviae Miltiorrhizae 15~20, Fructus Schisandrae Chinensis 5~30. The medical composition in this invention has a reasonable compounding, a high degree of efficacy for any phase of Psoriasis and less poisonous side effect.
Description
Technical field
The present invention relates to a kind of is the pharmaceutical composition of raw material with the Chinese herbal medicine, the psoriatic pharmaceutical composition of particularly a kind of treatment.
Background technology
Psoriasis is " psoriasis " again, is a kind of common chronic inflammatory disease dermatoses, has the characteristics of intractable and recurrent, its skin lesion feature is to be covered with the silvery white squama of multilamellar on red pimple or the speckle, obvious seasonal is arranged, and most of patients state of an illness spring, winter increase the weight of, and alleviate summer.Whole nation total prevalence rate is 0.72 ‰, and the male is more than the women, and the north is more than south, and the city is higher than the rural area.Just send out an age male and be 20-39 year, the women is maximum for 15-39 year.Sickness rate is on the rise over past ten years.Think relevant with industrial pollution and working environment.
Though psoriasis does not directly influence life, but healthy and physical and mental health are had a direct impact.The main cause active oxygen of psoriasis is harmful product of body metabolism, is impregnated between blood cell in the matter, causes the human body environment pollution, the change of the pure matter of blood.Heat in blood, dry, the blood stasis of blood occur, accumulate stagnant resistance and too much cause pestilent toxicity to be sent out in skin.With the passing of time hematozemia wound essence is delayed in outbreak repeatedly all the year round, the course of disease, failure of skin and muscle to be nourished, and uninteresting pruritus, health is wrecked in the insomnia of overtaxing one's nerves.The delay recurrence increases the weight of year by year, and desquamation blood stasis, pruritus due to dryness bring great misery to body and mind unbearably!
The onset of psoriasis reason has many-sided theories such as heredity, immunologic function disorder, direct stimulation, trauma infection contamination at present, but does not still have clearly final conclusion; Doctor trained in Western medicine does not have specific short yet.At present many patients are because of arbitrarily abusing cell toxicant class antineoplastic agents such as aminopterin, ethyliminum, bimolane, cyclophosphamide, and hormone medicine treatments such as dexamethasone, prednisone, betamethasone and import injection triamcinolone, make body liver, kidney and immunologic function be subjected to more serious inhibition and damage.Part patient with after though certain short run effect is arranged, not long-time after the drug withdrawal, but the toxic and side effects that state of an illness knock-on increases the weight of to worsen appears; Many patients are deeply hurt.
Summary of the invention
Technical problem to be solved by this invention is at the deficiencies in the prior art, provides the treatment that a kind of compatibility is reasonable, side effect is little, therapeutic effect is good psoriatic pharmaceutical composition.
Technical problem to be solved by this invention is to realize by following technical scheme.The present invention is the psoriatic pharmaceutical composition of a kind of treatment, is characterized in, it is the medicament of being made by following materials of weight proportions,
Radix Codonopsis 10-30 Rhizoma Atractylodis Macrocephalae 1-5 Fructus Crataegi (parched to brown) 10-30
Fructus Hordei Germinatus 1-5 Poria 1-5 Semen Raphani 1-5
Radix Glycyrrhizae 10-30 Radix Salviae Miltiorrhizae 15-20 Fructus Schisandrae Chinensis 5-30.
Technical problem to be solved by this invention can also further realize by following technical scheme.The psoriatic pharmaceutical composition of above-described a kind of treatment is characterized in, the weight proportion of each raw material is,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
Pharmaceutical composition of the present invention can be made the medicament of any dosage form of acceptable clinically, preferred particulates agent, pill, capsule, tablet.
Technical problem to be solved by this invention can also further realize by following technical scheme.The psoriatic pharmaceutical composition of above-described a kind of treatment is characterized in, the preparation method of described pill is, takes by weighing each raw material in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Below be that the inventor does the psoriatic clinical experiment effect of the medicine composite for curing of the present invention data of using.
One, medicine.By inventor's self-control, make Radix Codonopsis 15, the Rhizoma Atractylodis Macrocephalae 3, Fructus Crataegi (parched to brown) 15, Fructus Hordei Germinatus 3, Poria 3, Semen Raphani 3, Radix Glycyrrhizae 15, Radix Salviae Miltiorrhizae 20, Fructus Schisandrae Chinensis 15 by following weight proportion.Its preparation method is, takes by weighing each raw material in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, and every ball contains raw material fine powder 3-5 gram.
Two, the using method of medicine is: pills, every day 2-3 time, about each 10 grams, children's reduces by half, and 1 month is a course of treatment, divides disease the lighter and seriously ill person by sick time length, sick the lighter's sick time is below 5 years, seriously ill person's sick time is more than 5 years, and sick the lighter takes 2-4 the course of treatment, and seriously ill person takes 4-6 the course of treatment.
Three, the present invention has curative effect preferably through clinical use, now is described as follows:
1, psoriatic's situation explanation.
Sick the lighter: total 49 examples, wherein: male 21 examples, 10-25 year 9 examples, 25-50 year 12 examples; Woman's 28 examples, 10-25 year 11 examples, 25-50 year 17 examples.
Seriously ill person: total 41 examples, wherein: male 29 examples, 10-25 year 9 examples, 25-50 year 20 examples; Woman's 12 examples, 10-25 year 4 examples, 25-50 year 8 examples.
2, curative effect judging standard.
Recovery from illness: skin lesion all disappear (or leave over be no more than 10%);
Produce effects: skin lesion disappears 50%～90%;
Invalid: skin lesion does not reduce;
Recovery from illness+produce effects is a total effective rate.
2, clinical treatment result.
Compared with prior art, drug regimen composition formula of the present invention is reasonable, evident in efficacy, and toxic and side effects is little, and each psoriasis pustulosa of each phase is all had significant curative effect, and anti-recurrence is strong.
The specific embodiment
Embodiment 1.The psoriatic pharmaceutical composition of a kind of treatment, it is the granule of being made by following materials of weight proportions,
Radix Codonopsis 10 Rhizoma Atractylodis Macrocephalaes 1 Fructus Crataegi (parched to brown) 10
Fructus Hordei Germinatus 1 Poria 1 Semen Raphani 1
Radix Glycyrrhizae 10 Radix Salviae Miltiorrhizaes 15 Fructus Schisandrae Chinensis 5.
Its preparation method is that technology extracts each materials of effective ingredients routinely, adds pharmaceutic adjuvant, makes granule.
Embodiment 2.The psoriatic pharmaceutical composition of a kind of treatment, it is the tablet of being made by following materials of weight proportions,
Radix Codonopsis 30 Rhizoma Atractylodis Macrocephalaes 5 Fructus Crataegi (parched to brown)s 30
Fructus Hordei Germinatus 5 Poria 5 Semen Raphanis 5
Radix Glycyrrhizae 30 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 30.
Its preparation method is that technology extracts each materials of effective ingredients routinely, adds pharmaceutic adjuvant, makes tablet.
Embodiment 3.The psoriatic pharmaceutical composition of a kind of treatment, it is the pill of being made by following materials of weight proportions,
Radix Codonopsis 20 Rhizoma Atractylodis Macrocephalaes 2 Fructus Crataegi (parched to brown)s 20
Fructus Hordei Germinatus 2 Poria 2 Semen Raphanis 2
Radix Glycyrrhizae 20 Radix Salviae Miltiorrhizaes 18 Fructus Schisandrae Chinensis 20.
Its preparation method is that technology extracts each materials of effective ingredients routinely, adds pharmaceutic adjuvant, makes pill.
Embodiment 4.The psoriatic pharmaceutical composition of a kind of treatment, it is the capsule of being made by following materials of weight proportions,
Radix Codonopsis 18 Rhizoma Atractylodis Macrocephalaes 4 Fructus Crataegi (parched to brown)s 18
Fructus Hordei Germinatus 4 Poria 4 Semen Raphanis 4
Radix Glycyrrhizae 18 Radix Salviae Miltiorrhizaes 16 Fructus Schisandrae Chinensis 10.
Its preparation method is that technology extracts each materials of effective ingredients routinely, adds pharmaceutic adjuvant, makes capsule.
Embodiment 5.The psoriatic pharmaceutical composition of a kind of treatment, it is the oral liquid of being made by following materials of weight proportions,
Radix Codonopsis 25 Rhizoma Atractylodis Macrocephalaes 2 Fructus Crataegi (parched to brown)s 25
Fructus Hordei Germinatus 2 Poria 2 Semen Raphanis 2
Radix Glycyrrhizae 25 Radix Salviae Miltiorrhizaes 17 Fructus Schisandrae Chinensis 25.
Its preparation method is that technology extracts each materials of effective ingredients routinely, adds pharmaceutic adjuvant, makes oral liquid.
Embodiment 6.The psoriatic pharmaceutical composition of a kind of treatment, it is the pill of being made by following materials of weight proportions,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
The preparation method of described pill is, takes by weighing each raw material in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Claims (4)
1, the psoriatic pharmaceutical composition of a kind of treatment is characterized in that, it is the medicament of being made by following materials of weight proportions,
Radix Codonopsis 10-30 Rhizoma Atractylodis Macrocephalae 1-5 Fructus Crataegi (parched to brown) 10-30
Fructus Hordei Germinatus 1-5 Poria 1-5 Semen Raphani 1-5
Radix Glycyrrhizae 10-30 Radix Salviae Miltiorrhizae 15-20 Fructus Schisandrae Chinensis 5-30.
2, the psoriatic pharmaceutical composition of a kind of treatment according to claim 1 is characterized in that, the weight proportion of each raw material is,
Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalaes 3 Fructus Crataegi (parched to brown)s 15
Fructus Hordei Germinatus 3 Poria 3 Semen Raphanis 3
Radix Glycyrrhizae 15 Radix Salviae Miltiorrhizaes 20 Fructus Schisandrae Chinensis 15.
3, the psoriatic pharmaceutical composition of a kind of treatment according to claim 1 is characterized in that described medicament is granule, pill, capsule, tablet.
4, the psoriatic pharmaceutical composition of a kind of treatment according to claim 3 is characterized in that, the preparation method of described pill is, takes by weighing each raw material in proportion, and mixed powder is broken into fine powder, crosses the 150-200 mesh sieve, adds Mel and makes honeyed pill, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100966258A CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100966258A CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1943732A true CN1943732A (en) | 2007-04-11 |
| CN100411672C CN100411672C (en) | 2008-08-20 |
Family
ID=38043526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100966258A Expired - Fee Related CN100411672C (en) | 2006-10-12 | 2006-10-12 | A medicinal composition for treatment of psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411672C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288618A (en) * | 2014-10-16 | 2015-01-21 | 史飞 | Traditional Chinese medicine composition for treating child psoriasis vulgaris |
| CN108030903A (en) * | 2017-12-14 | 2018-05-15 | 珠海横琴新区德群中医药科学研究院有限公司 | One kind is used to treat psoriasic Chinese medicine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1290569C (en) * | 2004-04-16 | 2006-12-20 | 李有凤 | External remedy for curing eczema |
-
2006
- 2006-10-12 CN CNB2006100966258A patent/CN100411672C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104288618A (en) * | 2014-10-16 | 2015-01-21 | 史飞 | Traditional Chinese medicine composition for treating child psoriasis vulgaris |
| CN104288618B (en) * | 2014-10-16 | 2017-07-21 | 史飞 | A kind of Chinese medicine composition for treating children's psoriasis vulgaris |
| CN108030903A (en) * | 2017-12-14 | 2018-05-15 | 珠海横琴新区德群中医药科学研究院有限公司 | One kind is used to treat psoriasic Chinese medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100411672C (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN1486740A (en) | Chinese medicine composition for treating cancer | |
| CN1092981C (en) | Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method | |
| CN1966067A (en) | Medicament for treating aplastic anemia | |
| CN1364628A (en) | Compound Chinese medicinal preparation for treating chronic diarrhea-chronic Xiehanning pill | |
| CN1943732A (en) | A medicinal composition for treatment of psoriasis | |
| CN1698808A (en) | Chinese medicinal composition for treating ulcer | |
| CN1931276A (en) | Headache treating Chinese medicine composition and its prepn process | |
| CN1049586C (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN1895489A (en) | Externally-applied medicinef or treating psoriasis | |
| CN1895593A (en) | Medicine for treating acne and its preparation | |
| CN1054541C (en) | Traditional Chinese medicine for treating mastosis | |
| CN1302799C (en) | Oral Chinese medicinal composition for treating virus myocarditis | |
| CN1140071A (en) | Anticancer drug and preparing method thereof | |
| CN1843492A (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN1296034C (en) | Halitosis removing toothpaste | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN101049491A (en) | Application of stomachic pill with cyperus and amomum | |
| CN1241607C (en) | External plaster for treating mammary gland proliferation, mammary lobe proliferation and mammary cystic proliferation | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN1111419C (en) | A kind of medicine for the treatment of cardiovascular and cerebrovascular vessel apoplexy and premonitory apoplexy symptom and preparation method thereof | |
| CN1253195C (en) | Anti-age capsule of traditional Chinese medicine and preparation method | |
| CN1385204A (en) | Antianaphylactic Chinese medicine preparation | |
| CN1308017C (en) | Medicine composition for treating eliminateion, dysentery and eruptive disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20131012 |